Takeda Pharmaceutical Company Limited 13F holders
382 funds reported a position in Takeda Pharmaceutical Company Limited in their 13F for the quarter ended 30 June 2026, together 104.3 million shares worth $1.67 billion. Against the quarter before, 53 opened a position, 146 added, 100 trimmed and 41 sold out; together they bought a net 6.2 million shares. The largest holders: Capital Research Global Investors, FMR LLC and Morgan Stanley.
What each fund did in TAK against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in TAK in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
5,013 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 214 reported a position in Takeda Pharmaceutical Company Limited: 27 opened one, 83 added, 42 trimmed and 21 sold out, a net 782,853 shares bought.
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 7 reported a position in Takeda Pharmaceutical Company Limited in a 13F for the quarter ended 30 June 2026. The largest: Capital Research Global Investors, 19.3 million shares worth $309.3 million, 0.0% of its reported book. New this quarter: Millennium Management, Point72 Asset Management. In the quarter, 5 funds added or opened a position and 2 trimmed or sold out; together they bought a net 3.1 million shares, about $49.7 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 19,297,680 | $309.3 million | 0.0% | +193,461 | added | 30 June 2026 | 13F |
| FMR LLC | 9,599,302 | $153.9 million | 0.0% | +2,481,816 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 2,568,000 | $41.2 million | 0.1% | -421,100 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 1,050,698 | $16.8 million | 0.0% | +1,050,698 | new | 30 June 2026 | 13F |
| Two Sigma Investments | 485,733 | $7.8 million | 0.0% | +174,033 | added | 30 June 2026 | 13F |
| Citadel Advisors | 168,128 | $2.7 million | 0.0% | -456,032 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 77,658 | $1.2 million | 0.0% | +77,658 | new | 30 June 2026 | 13F |
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Capital Research Global Investors | 19,297,680 | 18.51% | $309.3 million | 0.04% | +193,461 | 13F |
| FMR LLC | 9,599,302 | 9.21% | $153.9 million | 0.01% | +2,481,816 | 13F |
| Morgan Stanley | 6,994,924 | 6.71% | $112.1 million | 0.01% | +525,324 | 13F |
| Adage Capital Partners GP, L.l.c. | 6,050,771 | 5.80% | $97.0 million | 0.14% | -374,213 | 13F |
| Goldman Sachs Group Inc. | 5,125,032 | 4.92% | $82.2 million | 0.01% | -493,696 | 13F |
| Brandes Investment Partners, LP | 4,539,347 | 4.35% | $72.8 million | 0.51% | +108,705 | 13F |
| Arrowstreet Capital, Limited Partnership | 3,732,924 | 3.58% | $59.8 million | 0.03% | +616,613 | 13F |
| BlackRock, Inc. | 3,688,166 | 3.54% | $59.1 million | 0.00% | +511,745 | 13F |
| Renaissance Technologies LLC | 2,568,000 | 2.46% | $41.2 million | 0.06% | -421,100 | 13F |
| Qube Research & Technologies Ltd | 2,207,432 | 2.12% | $35.4 million | 0.04% | new | 13F |
| First Trust Advisors LP | 2,114,912 | 2.03% | $33.9 million | 0.02% | +143,838 | 13F |
| D. E. Shaw & Co., Inc. | 2,049,467 | 1.97% | $32.9 million | 0.02% | -553,076 | 13F |
| Managed Asset Portfolios, LLC | 1,823,884 | 1.75% | $29.2 million | 3.34% | +25,486 | 13F |
| Northern Trust Corp. | 1,740,313 | 1.67% | $27.9 million | 0.00% | -220,725 | 13F |
| Van Eck Associates Corp. | 1,674,005 | 1.61% | $26.8 million | 0.02% | -586,099 | 13F |
| Envestnet Asset Management Inc. | 1,598,174 | 1.53% | $25.6 million | 0.01% | +186,247 | 13F |
| AQR Capital Management LLC | 1,525,686 | 1.46% | $24.5 million | 0.01% | +631,263 | 13F |
| Quantinno Capital Management LP | 1,402,650 | 1.35% | $22.5 million | 0.03% | +113,324 | 13F |
| Wells Fargo & Company | 1,150,820 | 1.10% | $18.4 million | 0.00% | +14,798 | 13F |
| Millennium Management LLC | 1,050,698 | 1.01% | $16.8 million | 0.01% | new | 13F |
| UBS Group AG | 911,319 | 0.87% | $14.6 million | 0.00% | -1,828,910 | 13F |
| Crossmark Global Holdings, Inc. | 783,835 | 0.75% | $12.6 million | 0.16% | +6,687 | 13F |
| JPMorgan Chase & Co. | 744,916 | 0.71% | $11.9 million | 0.00% | +290,935 | 13F |
| Stifel Financial Corp. | 722,863 | 0.69% | $11.6 million | 0.01% | +94,313 | 13F |
| BNP Paribas Financial Markets | 714,143 | 0.68% | $11.4 million | 0.01% | +523,730 | 13F |
| Royal Bank of Canada | 692,900 | 0.66% | $11.1 million | 0.00% | +78,049 | 13F |
| Focus Partners Wealth | 679,950 | 0.65% | $10.9 million | 0.01% | +197,563 | 13F |
| Charles Schwab Investment Management Inc. | 619,021 | 0.59% | $9.9 million | 0.00% | +78,673 | 13F |
| Creative Planning | 584,777 | 0.56% | $9.4 million | 0.01% | +41,781 | 13F |
| American Century Companies Inc. | 584,560 | 0.56% | $9.4 million | 0.00% | +69,201 | 13F |
| LPL Financial LLC | 555,228 | 0.53% | $8.9 million | 0.00% | +81,021 | 13F |
| Balyasny Asset Management L.P. | 511,336 | 0.49% | $8.2 million | 0.01% | +370,758 | 13F |
| Two Sigma Investments, LP | 485,733 | 0.47% | $7.8 million | 0.01% | +174,033 | 13F |
| US Bancorp | 466,714 | 0.45% | $7.5 million | 0.01% | -43,511 | 13F |
| PFM Health Sciences, LP | 444,173 | 0.43% | $7.1 million | 0.62% | new | 13F |
| Bleakley Financial Group, LLC | 432,956 | 0.42% | $6.9 million | 0.09% | +1,354 | 13F |
| Raymond James Financial Inc. | 408,739 | 0.39% | $6.6 million | 0.00% | +96,723 | 13F |
| Citigroup Inc. | 396,457 | 0.38% | $6.4 million | 0.00% | +38,283 | 13F |
| Federated Hermes, Inc. | 376,858 | 0.36% | $6.0 million | 0.01% | -5,393 | 13F |
| QRG Capital Management, Inc. | 372,752 | 0.36% | $6.0 million | 0.05% | +5,064 | 13F |
| Ethic Inc. | 365,253 | 0.35% | $5.9 million | 0.07% | +30,417 | 13F |
| Vestmark Advisory Solutions, Inc. | 351,770 | 0.34% | $5.6 million | 0.05% | +5,948 | 13F |
| Assetmark, Inc. | 314,687 | 0.30% | $5.0 million | 0.01% | +87,071 | 13F |
| Mariner, LLC | 308,157 | 0.30% | $4.9 million | 0.01% | +73,169 | 13F |
| Bank of America Corp. | 307,312 | 0.29% | $4.9 million | 0.00% | -12,657 | 13F |
| HRT Financial LP | 278,706 | 0.27% | $4.5 million | 0.01% | +152,632 | 13F |
| Hudson Bay Capital Management LP | 275,000 | 0.26% | $4.4 million | 0.02% | new | 13F |
| Hantz Financial Services, Inc. | 269,650 | 0.26% | $4.3 million | 0.06% | -13,388 | 13F |
| Natixis Advisors, LLC | 268,328 | 0.26% | $4.3 million | 0.01% | -55,706 | 13F |
| Pathstone Holdings, LLC | 239,306 | 0.23% | $3.8 million | 0.01% | -1,987 | 13F |
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on TAK
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 758,900 | $12.2 million | 30 June 2026 | 13F |
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
None in the last twelve months: no holder crossed 5%, changed materially, or filed an annual 13G in the window.
Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 9 October 2026 | 6 | $18.52 | SEC |
| 8 October 2026 | 6 | $18.37 | SEC |
| 2 October 2026 | 735 | $17.86 | SEC |
| 25 September 2026 | 144 | $18.59 | SEC |
| 11 September 2026 | 13,226 | $18.11 | SEC |
| 9 September 2026 | 5 | $18.32 | SEC |
| 8 September 2026 | 53 | $18.45 | SEC |
| 4 September 2026 | 34 | $18.71 | SEC |